Julie Doostzadeh

Julie Doostzadeh has extensive work experience in the field of clinical operations and scientific research. Julie is currently serving as the Executive Director of Clinical Operations at Denovo Biopharma, where they have been working since 2022. Prior to this, they held the role of Senior Director of Clinical Operations at Denovo Biopharma from April to November 2022.

Before joining Denovo Biopharma, Julie worked at AstraZeneca as an Associate Director of Clinical Operations from 2019 to 2022. Julie also gained experience at Gilead Sciences as an Associate Director of Clinical Operations from 2014 to 2019.

Julie's career also includes positions at NASA & Jeminix Clinical Research as Chief Scientist/Clinical Operations/Consultant from 2012 to 2014, Abbott as a Senior Advisor from 2006 to 2011, The Parkinson's Institute as a Clinical Research Scientist/Acting Program Manager from 2003 to 2006, Advanced Bio Lab Inc. as a Co-Founder/Clinical Director from 2001 to 2003, and DNA Sciences Inc. as a Clinical Scientist from 1999 to 2001.

Julie started their career at MD. Anderson Cancer Center as a Clinical Research Associate and Postdoctoral Trainee from 1997 to 1999. Julie also worked at CNAM, INSERM, Pasteur Institute as a Graduate Research Fellow and College Teacher Assistant from 1991 to 1996.

Julie Doostzadeh holds a Ph.D in Molecular and Cell Pathology from Sorbonne University. The duration of their studies and the specific years of enrollment are not provided.